Cancer research in the United States: Dying by a thousand paper cuts

Authors

  • Hagop Kantarjian MD,

    Corresponding author
    1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas
    • Corresponding author: Hagop Kantarjian, MD, Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Unit 428, Houston, TX 77030; Fax: (713) 794-4297; hkantarj@mdanderson.org

    Search for more papers by this author
  • David J. Stewart MD, RCPC,

    1. Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Search for more papers by this author
  • Leonard Zwelling MD

    1. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Search for more papers by this author

Abstract

The authors discuss cancer research in the United States and the implications of bureaucratic burdens on the conduct and cost of research and, consequently, the cost of drugs and health care. They propose potential remedial solutions.

Ancillary